These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 29198335)
1. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review. Ahir BK; Ozer H; Engelhard HH; Lakka SS Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335 [TBL] [Abstract][Full Text] [Related]
2. Role of micro-RNA (miRNA) in pathogenesis of glioblastoma. Luo JW; Wang X; Yang Y; Mao Q Eur Rev Med Pharmacol Sci; 2015; 19(9):1630-9. PubMed ID: 26004603 [TBL] [Abstract][Full Text] [Related]
3. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas. Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490 [TBL] [Abstract][Full Text] [Related]
4. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells. C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939 [TBL] [Abstract][Full Text] [Related]
5. Short non-coding RNA sequencing of glioblastoma extracellular vesicles. de Mooij T; Peterson TE; Evans J; McCutcheon B; Parney IF J Neurooncol; 2020 Jan; 146(2):253-263. PubMed ID: 31912278 [TBL] [Abstract][Full Text] [Related]
6. Recent advances of the regulation roles of MicroRNA in glioblastoma. Yan C; Kong X; Gong S; Liu F; Zhao Y Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in human glioblastoma: from bench to beside. Wang H; Xu T; Jiang Y; Yan Y; Qin R; Chen J Front Biosci (Landmark Ed); 2015 Jan; 20(1):105-18. PubMed ID: 25553442 [TBL] [Abstract][Full Text] [Related]
8. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells. Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270 [TBL] [Abstract][Full Text] [Related]
9. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114 [TBL] [Abstract][Full Text] [Related]
10. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles. Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334 [TBL] [Abstract][Full Text] [Related]
11. Effect of Necrosis on the miRNA-mRNA Regulatory Network in CRT-MG Human Astroglioma Cells. Ahn SH; Ahn JH; Ryu DR; Lee J; Cho MS; Choi YH Cancer Res Treat; 2018 Apr; 50(2):382-397. PubMed ID: 28546527 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin. Herman A; Gruden K; Blejec A; Podpečan V; Motaln H; Rožman P; Hren M; Zupančič K; Veber M; Verbovšek U; Lah Turnšek T; Porčnik A; Koršič M; Knežević M; Jeras M PLoS One; 2015; 10(5):e0125791. PubMed ID: 25950799 [TBL] [Abstract][Full Text] [Related]
13. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Sana J; Busek P; Fadrus P; Besse A; Radova L; Vecera M; Reguli S; Stollinova Sromova L; Hilser M; Lipina R; Lakomy R; Kren L; Smrcka M; Sedo A; Slaby O Sci Rep; 2018 Feb; 8(1):2836. PubMed ID: 29434344 [TBL] [Abstract][Full Text] [Related]
14. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures. Yerukala Sathipati S; Huang HL; Ho SY BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650 [TBL] [Abstract][Full Text] [Related]
15. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma. Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080 [TBL] [Abstract][Full Text] [Related]
16. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes. Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456 [TBL] [Abstract][Full Text] [Related]
17. Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview. Chu PM; Ma HI; Chen LH; Chen MT; Huang PI; Lin SZ; Chiou SH Cell Transplant; 2013; 22(4):741-53. PubMed ID: 23127968 [TBL] [Abstract][Full Text] [Related]
18. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy. Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Shea A; Harish V; Afzal Z; Chijioke J; Kedir H; Dusmatova S; Roy A; Ramalinga M; Harris B; Blancato J; Verma M; Kumar D Cancer Med; 2016 Aug; 5(8):1917-46. PubMed ID: 27282910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]